This month we interview Ignacio Vieira, Audit & Certification, Healthcare, DSG & AZ Health Consortium Director at Azierta who talks to us about AZIERTA CARE and the importance of diversifying markets. A talk in which our expert discusses the birth of the new unit, Azierta Care, its main services and its launch as an international boutique consultancy […]
Archive for April 21st, 2022
Possible sources and classification of impurities
Impurities are defined in ICH Q6A guideline as “Any component of the drug product that is not the chemical entity defined as the drug substance or an excipient in the drug product. The impurities in drug products can be originated not only in the drug substance or inert ingredients used for formulating a drug product; […]
Titanium dioxide: the use as a food additive of E171
On February 2020 the EU published that titanium dioxide must be classified as carcinogen if inhaled (Carc. 2, H351 (inhalation) in certain powdered forms under the CLP Regulation. Moreover, on May 2021 the European Food Safety Authority (EFSA) published an updated safety assessment of the food additive titanium dioxide (E 171) concluding that titanium dioxide can […]
Ángel Fernández visits our company
This week we received a visit from Ángel Fernández, Global Senior Executive, Pharmaceuticals, Business Advisor, Health Care, MSD SVP Europe, US, Latam. Ángel met with the President of Azierta, Ángel Navarro, and part of the management team to learn first-hand about the work that our company carries out in the different business units. The experience […]